Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma. | Front Immunol | 2023 | 37901209 | PubTator, text mining | PubMed |
| Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression. | Cureus | 2023 | 37900496 | PubTator, text mining | PubMed |
| Advances in mRNA-Based Cancer Vaccines. | Vaccines (Basel) | 2023 | 37897001 | PubTator, text mining | PubMed |
| Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery. | Pharmaceutics | 2023 | 37896218 | PubTator, text mining | PubMed |
| Unveiling the Immune Microenvironment's Role in Breast Cancer: A Glimpse into Promising Frontiers. | Int J Mol Sci | 2023 | 37895012 | PubTator, text mining | PubMed |
| Photodynamic Therapy Combined with Ferroptosis Is a Synergistic Antitumor Therapy Strategy. | Cancers (Basel) | 2023 | 37894410 | PubTator, text mining | PubMed |
| Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37894344 | PubTator, text mining | PubMed |
| CAR T-Cells in Acute Lymphoblastic Leukemia: Current Status and Future Prospects. | Biomedicines | 2023 | 37893067 | PubTator, text mining | PubMed |
| Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment. | Biomedicines | 2023 | 37892995 | PubTator, text mining | PubMed |
| Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging Strategies. | Bioengineering (Basel) | 2023 | 37892958 | PubTator, text mining | PubMed |
| Heterogeneity and individualized treatment of microenvironment in glioblastoma (Review). | Oncol Rep | 2023 | 37888767 | PubTator, text mining | PubMed |
| Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review). | Int J Oncol | 2023 | 37888583 | PubTator, text mining | PubMed |
| MicroRNAs: Small but Key Players in Viral Infections and Immune Responses to Viral Pathogens. | Biology (Basel) | 2023 | 37887044 | PubTator, text mining | PubMed |
| Ray of dawn: Anti-PD-1 immunotherapy enhances the chimeric antigen receptor T-cell therapy in Lymphoma patients. | BMC Cancer | 2023 | 37872514 | PubTator, text mining | PubMed |
| Tumor immunology meets oncology (TIMO) XVII, April 20-22 2023 in Halle/Saale, Germany. | Cancer Immunol Immunother | 2023 | 37872395 | PubTator, text mining | PubMed |
| Plasma extrachromosomal circular DNA is a pathophysiological hallmark of short-term intensive insulin therapy for type 2 diabetes. | Clin Transl Med | 2023 | 37859516 | PubTator, text mining | PubMed |
| A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity. | J Exp Clin Cancer Res | 2023 | 37858248 | PubTator, text mining | PubMed |
| From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress. | Signal Transduct Target Ther | 2023 | 37857607 | PubTator, text mining | PubMed |
| Development and validation of stable ferroptosis- and pyroptosis-related signatures in predicting prognosis and immune status in breast cancer. | J Cell Mol Med | 2023 | 37849388 | PubTator, text mining | PubMed |
| Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review. | Front Oncol | 2023 | 37841422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=18